A complete application in a minute
Tailored resume and cover letter, ready to send.
The Office of Intramural Training & Education at NIH's National Cancer Institute in Bethesda, MD invites applications for a postdoctoral fellow to study how dysregulated gene expression shapes anti-tumor immunity. The focus is osteosarcoma, using RUNX transcription factors to understand immune evasion by tumor cells.
Ph.D. or equivalent by start date and fewer than two years of postdoctoral experience are required.
NIH National Cancer Institute, Bethesda, MD and surrounding area
Scientific focus area
Cancer Biology,Immunology,Molecular Biology and Biochemistry
The laboratory of Dr. Jing Huang at the NIH National Cancer Institute is now seeking a motivated and intellectually curious postdoctoral fellow to investigate how dysregulated gene expression shapes anti-tumor immunity.
Our lab's research focuses on osteosarcoma, using RUNX transcription factors as models to understand how tumor cell-intrinsic programs regulate immune evasion. Prospective candidates will investigate the mechanisms which control the limited efficacy of immune checkpoint blockades in osteosarcoma. Our goal is to identify therapeutic strategies for this aggressive cancer, which primarily affects children and adolescents.
Prospective candidates should have a Ph.D. or equivalent degree, or expect to receive one within six months of applying, and have fewer than two years of postdoctoral experience at the time of application. Applicants should possess a strong background in immunology, molecular biology, and/or epigenetic regulation. Research experience in cancer biology, as well as experience with mouse models and osteosarcoma, is a major advantage.
Strong written and verbal communication skills are a must. The self-initiative to pursue independent research and the ability to work collaboratively are also required.
This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs. U.S. citizens and permanent residents are eligible to apply. NIH welcomes foreign nationals with the exception of individuals from this list .